Clinical trials
Completed Spinal Fractures trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
78 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 6 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 6 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 5 |
| 2016 | 6 |
| 2017 | 5 |
| 2018 | 7 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 78 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centre Hospitalier Universitaire de Nice | 3 |
| Eli Lilly and Company | 2 |
| Elisabeth-TweeSteden Ziekenhuis | 2 |
| Medical University of Vienna | 2 |
| University of Waterloo | 2 |
| Uppsala University | 2 |
| Vexim SA | 2 |
| 153rd Hospital of Chinese People's Liberation Army | 1 |
| AO Clinical Investigation and Publishing Documentation | 1 |
| Ain Shams University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Spinal Fractures | 78 |
| Osteoporosis | 31 |
| Back Pain | 8 |
| Fractures, Bone | 6 |
| Kyphosis | 6 |
| Bone Diseases, Metabolic | 4 |
| Osteoporosis, Postmenopausal | 4 |
| Osteoporotic Fractures | 4 |
| Spinal Stenosis | 4 |
| Spondylolisthesis | 4 |
Trials
Showing 51 to 75 of 78. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.